A new class of potent non-imidazole H3 antagonists: 2-Aminoethylbenzofurans

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 3, 2004, Pages 689-693

  Cowart, Marlon ^a   Pratt, John K ^a   Stewart, Andrew O ^a   Bennani, Youssef L ^a,b   Esbenshade, Timothy A ^a   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

^b ATHERSYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; HISTAMINE H3 RECEPTOR ANTAGONIST;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG PENETRATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 1642452635     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.032     Document Type: Article

References (32)

1. For reviews, see: Leurs R., Blandina P., Tedford C., Timmerman H. Trends Pharmacol. Sci. 19:1998;177.
2. 3 Receptor: A Target for New Drugs; Leurs, R., Timmerman, H., Eds.; Pharmacochemistry Library v. 30; Elsevier: Amsterdam, the Netherlands, 1998.
3. Stark H., Arrang J.M., Ligneau X., Garbarg M., Ganellin C.R., Schwartz J.C., Schunack W. King F.D., Oxford A.W. Progress in Medicinal Chemistry, v. 38. 2001;279-309 Elsevier Science.
4. Stark H. Exp. Opin. Ther. Patents. 13:2003;851.
5. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. Pharmacol. Rev. 49:1997;253.
6. Brown R.E., Stevens D.R., Haas H.L. Prog. Neurobiol. 38:2001;279.
7. (g) Cowart, M.; Altenbach, R.; Black, L.; Faghih, R.; Zhao, C.; Hancock, A. A. Mini-Reviews in Medicinal Chemistry, submitted 2003.
8. Ganellin C.R. Ganellin C.R., Parson M.E. Pharmacology of Histamine Receptors. 1982;11-102 Wright, Bristol, UK.
9. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. J. Biol. Chem. 275:2000;36781.
10. Liu C., Ma X., Jiang X., Wilson S.J., Hofstra C.L., Blevitt J., Pyati J., Li X., Chai W., Carruthers N., Lovenberg T.W. Mol. Pharmacol. 59:2001;420.
11. Hofstra C.L., Pragnya D.J., Thurmond R.L., Fung-Leung W.-P. J. Pharmacol. Exp. Ther. 305:2003;1212.
12. Lovenberg T.W., Roland B.L., Wilson S.J., Jiang Z., Jayashree P., Huvar A., Jackson M.R., Erlander M.R. Mol. Pharm. 55:1999;1101.
13. Lovenberg T.W., Pyati J., Chang J., Wilson S.J., Erlander M.G. J. Pharmacol. Exp. Ther. 293:2000;771.
14. Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., Schunack W., Ganellin C.R., Schwartz J.-C., Arrang J.-M. Nature. 408:2000;860.
15. Rouleau A., Ligneau X., Tardivel-Lacombe J., Morisset S., Gbahou F., Schwartz J.-C., Arrang J.-M. Br. J. Pharmacol. 135:2002;383.
16. Fox G.B., Pan J.B., Radek R.J., Lewis A.M., Bitner R.S., Esbenshade T.A., Faghih R., Bennani Y.L., Williams M., Yao B.B., Decker M.W., Hancock A.A. J. Pharmacol. Exp. Ther. 305:2003;897.
17. (a) Hancock, A. A.; Bush, E. N.; Shapiro, R.; Nuss, M.; Segel, V.; Wilcox, D. M.; Droz, B.; Dickinson, R. W.; Jacobson, P. B.; Bennani, Y. L.; Esbenshade, T. A.; Faghih, R. 225th ACS National Meeting, New Orleans, March 23-27, 2003, MEDI-003.
18. (b) Yates, S. L.; Powlowski, G. P.; Babu, J. S.; Rajagopalan, R.; Wawro, W. J.; Tedford, C. E. 225th ACS National Meeting, New Orleans, March 23-27, 2003, MEDI-002.
19. (c) Bjenning, C.; Liu, W.; Rimvall, K. International Congress Series, 2001, 1224 (Histamine Research in the New Millennium), 451-452.
20. Liedtke S., Flau K., Kathmann M., Schlicker E., Stark H., Meier G., Schunack W. Nauyn-Schmiedeberg's Arch. Pharm. 367:2003;43.
21. McLeod R.L., Rizzo C.A., West R.E. Jr., Aslanian R., McCormick K., Bryant M., Hsieh Y., Korfmacher W., Mingo G.G., Varty L., Williams S.M., Shih N.-Y., Egan R.W., Hey J.A. J. Pharmacol. Exp. Ther. 305:2003;1037.
22. Lin J.H., Lu A.Y.H. Clin. Pharmacokinet. 35:1998;361.
23. Boxenbaum H. J. Pharm. Pharmaceut. Sci. 2:1999;45.
24. Ganellin C.R., Leurquin F., Piripitsi A., Arrang J.-M., Garbarg M., Ligneau X., Schunack W., Schwartz J.-C. Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.). 331:1998;395.
25. Meier G., Apelt J., Reichert U., Grassman S., Ligneau X., Elz S., Leurquin F., Ganellin C.R., Schwartz J.-C., Schunack W., Stark H. Eur. J. Pharm. Sci. 13:2001;249.
26. Chai W., Breitenbucher J.G., Kwok A., Li X., Wong V., Carruthers N.I., Lovenberg T.W., Mazur C., Wilson S.J., Axe F.U., Jones T.K. Bioorg. Med. Chem. Lett. 13:2003;1767.
27. Shah C., McAtee L., Breitenbucher J.G., Rudolph D., Li X., Lovenberg T.W., Mazur C., Wilson S.J., Carruthers N.I. Bioorg. Med. Chem. Lett. 12:2002;3309.
28. Faghih R., Dwight W., Pan J.B., Fox G.B., Krueger K.M., Esbenshade T.A., McVey J.M., Marsh K., Bennani Y.L., Hancock A.A. Bioorg. Med. Chem. Lett. 13:2003;1325.
29. Faghih R., Dwight W., Vasudevan A., Dinges J., Conner S.E., Esbenshade T.A., Bennani Y.L., Hancock A.A. Bioorg. Med. Chem. Lett. 12:2003;3077.
30. Veber D.F., Johnson S.R., Chen H.-Y., Smith B.R., Ward K.W., Kopple K.D. J. Med. Chem. 45:2002;2615.
31. Wenlock M.C., Austin R.P., Barton P., Davis A.M., Leeson P.D. J. Med. Chem. 46:2003;1250.
32. Nijhuis W.H.N., Verboom W., El-Fadl A.A., van Hummel G.J., Reinhoudt D.N. J. Org. Chem. 54:1989;209.